RxDoctor Payments Data

Fariha Atmar, PA

Physician Assistant · Gridley, CANPI 1891710661

Payments from drug & device makers

$1,520in general payments, 2019–2025

Across 66 payments — averaging $23.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$302
  • AbbVie$195
  • Novo Nordisk$190
  • Gilead$135
  • Boehringer Ingelheim$112
  • Exact Sciences$96
  • plus $490 from 14 others

What the payments were for

  • Food & beverage$1,520100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,520 in reported general payments places this provider in the 75th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Medicare billing

Part B allowed, 2024
$35,728
Medicare patients
90
Services billed
566

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin71$72,346
OzempicSemaglutide49$48,475
JanuviaSitagliptin Phosphate44$44,929
EliquisApixaban20$21,378
Trelegy ElliptaFluticasone/Umeclidin/Vilanter21$15,882
MounjaroTirzepatide14$14,433
Albuterol Sulfate HfaAlbuterol Sulfate159$6,331
BreynaBudesonide/Formoterol Fumarate22$3,514
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog11$3,478
Lantus SolostarInsulin Glargine,hum.Rec.Anlog23$1,992
Atorvastatin Calcium179$1,900
Insulin Lispro Kwikpen U-100Insulin Lispro15$1,719
Ventolin HfaAlbuterol Sulfate21$1,642
Fluticasone-SalmeterolFluticasone Propion/Salmeterol22$1,098
Gabapentin138$1,035

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$112$72,34671 claims
Novo NordiskOzempic$190$48,47549 claims
PfizerEliquis$67$21,37820 claims
GSKTrelegy Ellipta$55$15,88221 claims
Lilly USA, LLCMounjaro$302$14,43314 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 10,423 physician assistant providers in California.

Other physician assistant in Gridley

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →